Studies of the effects of atrial natriuretic peptide on the coronary circulation have yielded
conflicting results in animals and have not been fully investigated in human subjects. To …

An intracoronary drug infusion protocol was employed to assess the hemodynamic effects of
synthetic atrial natriuretic peptide in normal subjects and to evaluate its actions on epicardial …

The effects of the synthetic 28-amino-acid alpha-human atrial natriuretic peptide (ANP) on
the proximal coronary arteries and coronary blood flow were evaluated in 17 patients …

The effects of atrial natriuretic peptide (ANP) infusion were determined in 9 subjects
undergoing cardiac catheterization that did not disclose heart disease. Data were obtained …

Studies were performed in isolated, Langendorff-perfused rat hearts and anesthetized dogs
to determine the effects of synthetic atrial natriuretic peptide (ANP 8-33) on the coronary …

SINCE the pioneering work by de Bold et all it has been recognized that atrial natriuretic
peptide (ANP) is released from mammalian atria and circulates as a hormone? 3 In addition …

Atrial natriuretic peptide has been reported to cause vasoconstriction, vasodilation or no
change of coronary vascular resistance in isolated perfused hearts or in open chest animal …

The effects of atrial natriuretic peptide (ANP) on proximal epicardial coronary artery
dimensions and coronary blood flow were examined in 7 awake dogs chronically …

Atriopeptin II has been reported to cause profound coronary vasoconstriction in the isolated
perfused guinea pig heart and in the blood perfused canine heart. Consequently, this study …

Plasma concentrations of atrial natriuretic peptide were measured in eight patients with
cardiac disease but normal resting right atrial pressure, during cardiac catheterization. No …